ARVINAS, INC. ARVN
- ARV-102 — Parkinson's Disease Phase 1
- ARV-102 — Progressive Supranuclear Palsy Phase 1
Home › Targets › leucine-rich repeat kinase 2
leucine-rich repeat kinase 2 (1 companies · 2 programs)
Companies with an active program directed at leucine-rich repeat kinase 2.